Literature DB >> 10417586

Split skin grafts in the treatment of pyoderma gangrenosum. A report of four cases.

S Cliff1, C A Holden, P R Thomas, R A Marsden, C C Harland.   

Abstract

BACKGROUND: Pyoderma gangrenosum (PG) is an uncommon necrotising, non-infective ulceration of the skin. The management of PG is aimed at limiting tissue destruction, promoting the healing of the wound, and providing an acceptable cosmetic result. However, skin grafting is normally avoided because of the potential risk of pathergy-the localization of skin damaged by trauma. REPORT: We describe the use of split skin grafts in the management of ulcerative pyoderma gangrenosum in 4 patients.
RESULTS: Our cases demonstrate that split skin grafts are a useful treatment modality in patients with ulcerative PG, producing a good cosmetic result. One case illustrates the importance of ensuring the disease is quiescent prior to grafting, to avoid pathergy. The other cases emphasise the need for prolonged immunosuppressive therapy to minimise the chance of reactivation of the disease process.
CONCLUSION: Our preliminary experience of 4 cases of ulcerative PG indicates that split skin grafts have a role to play in its management. The ultimate cosmetic result is considered to be superior to allowing the wound to heal by secondary intention. To limit the risk of pathergy developing, our experience suggests a role for prolonged courses of immunosuppressive therapy. The most effective dose and duration of immunosuppressive therapy in patients with PG treated with split skin grafts remains to be determined. A controlled study would be of benefit to compare it with other current treatment options.

Entities:  

Mesh:

Year:  1999        PMID: 10417586     DOI: 10.1046/j.1524-4725.1999.08193.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  5 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  A surgeon's nightmare: pyoderma gangrenosum with pathergy effect mimicking necrotising fasciitis.

Authors:  Amanda Mun Yee Slocum
Journal:  BMJ Case Rep       Date:  2017-12-20

3.  Extraintestinal Complications of Inflammatory Bowel Disease.

Authors:  Ad A. van Bodegraven; Ben A. C. Dijkmans; Paul Lips; Tom J. Stoof; A. Salvador Peña; Stephan G. M. Meuwissen
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

4.  A favourable response to surgical intervention and hyperbaric oxygen therapy in pyoderma gangrenosum.

Authors:  Ilknur Altunay; Asli Kucukunal; Sezgi Sarikaya; Gulsen Tukenmez Demirci
Journal:  Int Wound J       Date:  2012-10-29       Impact factor: 3.315

5.  Pyoderma gangrenosum following reduction mammaplasty.

Authors:  Amy M Simon; Dana Khuthaila; Dennis C Hammond; Albert Andres
Journal:  Can J Plast Surg       Date:  2006
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.